Summary & Overview
HCPCS G9383: HCV Screening Within 12-Month Reporting Period
HCPCS Level II code G9383 documents that a patient received screening for hepatitis C virus (HCV) infection within a 12-month reporting period. As a preventive screening measure, this code supports clinical quality reporting and public health efforts to identify and treat HCV, a nationally significant infectious disease with implications for chronic liver disease and population health management. Recording HCV screening consistently enables tracking of screening rates across healthcare settings and supports care continuum objectives.
Key payers addressed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of the code’s clinical purpose, common payer coverage contexts, and the typical service settings where the code is captured. The publication also outlines benchmarking considerations and policy context relevant to screening metrics and quality reporting.
This resource provides guidance on the clinical context for G9383, how the code functions in documentation and reporting workflows, and what stakeholders should consider when interpreting screening performance measures. Data not available in the input for Associated Taxonomies, ICD-10 diagnoses, and related codes.
Billing Code Overview
HCPCS Level II code G9383 represents that a patient received screening for HCV infection within the 12-month reporting period. This code documents a preventive screening service focused on hepatitis C virus (HCV) detection.
-
Service type: HCV screening service
-
Typical site of service: Outpatient or ambulatory care settings where preventive screening is provided, including primary care offices, community clinics, and outpatient screening programs.
Data not available in the input for Associated Taxonomies, ICD-10 Diagnoses, and Related Codes.
Clinical & Coding Specifications
Clinical Context
A 45-year-old patient presents to a primary care clinic for an annual preventive visit. The patient has risk factors for hepatitis C virus (HCV) infection including a history of prior intravenous drug use in their twenties and a current diagnosis of chronic liver enzyme elevations. The clinician documents risk assessment, obtains informed consent for screening, and orders HCV antibody testing with reflex to HCV RNA if positive. A venipuncture is performed in the clinic laboratory; the specimen is processed and sent to the reference lab. Results are returned within a few days; a positive antibody with detectable RNA triggers linkage to care with infectious disease or hepatology and documentation of counseling and treatment planning within the 12-month reporting period. Billing for population health reporting or quality measure capture uses HCPCS Level II code G9383 to indicate the patient received HCV screening during the reporting year.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 | Increased procedural services | Use when unusually high complexity in counseling or documentation for HCV screening significantly increases work beyond typical levels. |
23 |